title: A partial trace amine-associated receptor 1 agonist exhibits properties consistent with a methamphetamine substitution treatment.
abstract: Recent evidence suggests that the trace amine-associated receptor 1 (TAAR1) plays a pivotal role in the regulation of dopamine (DA) transmission and psychostimulant action. Several selective TAAR1 agonists have previously shown efficacy in models of cocaine addiction. However, the effects of TAAR1 activation on methamphetamine (METH)-induced behaviours are less well understood, as indeed are the underlying neurochemical mechanisms mediating potential interactions between TAAR1 and METH. Here, in a progressive ratio schedule of reinforcement the partial TAAR1 agonist, RO5263397, reduced the break-point for METH self-administration, while significantly increasing responding maintained by food reward. Following self-administration and extinction training, RO5263397 completely blocked METH-primed reinstatement of METH seeking. Moreover, when used as a substitute, unlike a low dose of METH, which sustained vigorous responding when substituting for the training dose of METH, RO5263397 was not self-administered at any dose, thus exhibiting no apparent abuse liability. Fast-scan cyclic voltammetry experiments showed that RO5263397 prevented METH-induced DA overflow in slices of the nucleus accumbens, while having no effect on DA transmission in its own right. Collectively, the present observations demonstrate that partial TAAR1 activation decreases the motivation to self-administer METH, blocks METH-primed reinstatement of METH seeking and prevents METH-induced DA elevations in the nucleus accumbens, and strongly support the candidacy of TAAR1-based medications as potential substitute treatment in METH addiction.
authors.affiliation: Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, UK.
authors.forename: Yue
authors.initials: Y
authors.lastname: Pei
authors.affiliation: Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, UK.
authors.forename: Aman
authors.initials: A
authors.lastname: Asif-Malik
authors.affiliation: Neuroscience, Ophthalmology and Rare Diseases Discovery & Translational Area, pRED, Roche Innovation Center Basel, Basel, Switzerland.
authors.forename: Marius
authors.initials: M
authors.lastname: Hoener
authors.affiliation: Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, UK.
authors.forename: Juan J
authors.initials: JJ
authors.lastname: Canales
mesh_terms: D019969:Amphetamine-Related Disorders; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage*; D004298:Dopamine / Q000378:metabolism; D058999:Drug-Seeking Behavior / Q000187:drug effects*; D008297:Male; D008694:Methamphetamine / Q000008:administration & dosage*; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism; D010080:Oxazoles / Q000494:pharmacology*; D051381:Rats; D020318:Rats, Long-Evans; D043562:Receptors, G-Protein-Coupled / Q000819:agonists*; D012054:Reinforcement, Psychology; D012201:Reward; D012646:Self Administration; D000095383:Trace Amine-Associated Receptors
chemical_list: D000697:Central Nervous System Stimulants; D004298:Dopamine; D008694:Methamphetamine; D010080:Oxazoles; D043562:Receptors, G-Protein-Coupled; D000095383:Trace Amine-Associated Receptors; C000596180:4-(3-fluoro-2-methylphenyl)-4,5-dihydrooxazol-2-ylamine
keywords: Addiction models; methamphetamine; trace amine-associated receptor 1